Vaccine for Prevention hryppa ynaktyvyrovannaya | Ultrix solution for i / m administration of 0.5 ml / dose, syringe 0, 5 ml
Special Price
$18.43
Regular Price
$26.00
In stock
SKU
BID527722
Release form
Solution for intramuscular injection
Solution for intramuscular injection
Release form
Solution for intramuscular injection
Packaging
Prefilled syringe 0.5 ml.
Pharmacological action of
The vaccine is a mixture of highly purified protective surface and internal antigens of influenza viruses type A (H1N1 and H3N2) and type B.
Pharmacological action - immunostimulatory.
Indications
Prevention of influenza. Vaccination is recommended for the following groups of people:
children from 6 years old
students of higher and secondary vocational educational institutions
working adults, especially employees of medical and educational institutions, transport, utilities
people suffering from chronic somatic diseases
people often suffering from acute respiratory diseases
adults over 60 years old.
Contraindications
allergic reactions to previous vaccinations with
flu vaccines allergic reactions to chicken protein and
vaccine components acute febrile illness or exacerbation of chronic
disease while breastfeeding.
Pregnancy and lactation
No information available. Clinical studies have not been conducted.
Special instructions
Do not enter iv.
In the rooms where vaccination is carried out, it is necessary to have drugs for anti-shock measures and stop the anaphylactic reaction.
The vaccinee must be monitored by a healthcare professional for 30 minutes after immunization.
Influence on the ability to drive vehicles and work with mechanisms. No information available.
Composition of
influenza viruses cultured in chicken embryos, inactivated, cleaved, represented by the strains:
A (H1N1) (15 Ѡ2.2) ?g hemagglutinin
A (H3N2) (15 Ѡ2.2) ?g hemagglutinin srd 15 Ѡ2.2) mcg hemagglutinin
excipient:
preservative (thiolate) - 42.5ֵ7.5 mcg or does not contain
preservative The antigenic composition of the vaccine changes every year in accordance with the epidemic situation and WHO recommendations.
Dosage and administration of
V / m, in the deltoid muscle.
The vaccine is administered once at a dose of 0.5 ml.
In mild ARVI, acute intestinal diseases, vaccination is carried out after normalization of temperature. Vaccinations are carried out after recovery (remission).
On the day of vaccination, vaccinees should be examined by a doctor / nurse with mandatory thermometry. At temperatures above 37 РC, vaccination is not carried out.
The drug is not suitable for use in ampoules or syringes with impaired integrity or labeling, with a change in physical properties (color, transparency), with an expired shelf life, violation of the requirements for storage conditions.
Side effects
Vaccine administration may be accompanied by local and general reactions.
Very rarely - at the injection site there may be reactions in the form of soreness, redness and swelling of the skin.
Extremely rare - individuals may experience general reactions in the form of increased fatigue, headache, dizziness, low-grade fever, runny nose, pharyngitis, cough, arthralgia, myalgia, and nausea. These reactions usually disappear on their own after 1-3 days.
In extremely rare cases - with high individual sensitivity, allergic reactions can be observed.
Drug Interactions
The vaccine can be used concurrently with other inactivated vaccines.
In this case, contraindications to each of the vaccines used should be taken into account, drugs should be administered to different parts of the body with different syringes.
Vaccination of patients receiving immunosuppressive therapy may be less effective.
Storage Conditions
At 2-8 РC (do not freeze).
Expiration
1 year.
Active ingredient
Vaccine for the prevention of influenza doped
Terms leave through pharmacies
In retseptu
lekarstvennaja form
Solution for
Solution for intramuscular injection
Packaging
Prefilled syringe 0.5 ml.
Pharmacological action of
The vaccine is a mixture of highly purified protective surface and internal antigens of influenza viruses type A (H1N1 and H3N2) and type B.
Pharmacological action - immunostimulatory.
Indications
Prevention of influenza. Vaccination is recommended for the following groups of people:
children from 6 years old
students of higher and secondary vocational educational institutions
working adults, especially employees of medical and educational institutions, transport, utilities
people suffering from chronic somatic diseases
people often suffering from acute respiratory diseases
adults over 60 years old.
Contraindications
allergic reactions to previous vaccinations with
flu vaccines allergic reactions to chicken protein and
vaccine components acute febrile illness or exacerbation of chronic
disease while breastfeeding.
Pregnancy and lactation
No information available. Clinical studies have not been conducted.
Special instructions
Do not enter iv.
In the rooms where vaccination is carried out, it is necessary to have drugs for anti-shock measures and stop the anaphylactic reaction.
The vaccinee must be monitored by a healthcare professional for 30 minutes after immunization.
Influence on the ability to drive vehicles and work with mechanisms. No information available.
Composition of
influenza viruses cultured in chicken embryos, inactivated, cleaved, represented by the strains:
A (H1N1) (15 Ѡ2.2) ?g hemagglutinin
A (H3N2) (15 Ѡ2.2) ?g hemagglutinin srd 15 Ѡ2.2) mcg hemagglutinin
excipient:
preservative (thiolate) - 42.5ֵ7.5 mcg or does not contain
preservative The antigenic composition of the vaccine changes every year in accordance with the epidemic situation and WHO recommendations.
Dosage and administration of
V / m, in the deltoid muscle.
The vaccine is administered once at a dose of 0.5 ml.
In mild ARVI, acute intestinal diseases, vaccination is carried out after normalization of temperature. Vaccinations are carried out after recovery (remission).
On the day of vaccination, vaccinees should be examined by a doctor / nurse with mandatory thermometry. At temperatures above 37 РC, vaccination is not carried out.
The drug is not suitable for use in ampoules or syringes with impaired integrity or labeling, with a change in physical properties (color, transparency), with an expired shelf life, violation of the requirements for storage conditions.
Side effects
Vaccine administration may be accompanied by local and general reactions.
Very rarely - at the injection site there may be reactions in the form of soreness, redness and swelling of the skin.
Extremely rare - individuals may experience general reactions in the form of increased fatigue, headache, dizziness, low-grade fever, runny nose, pharyngitis, cough, arthralgia, myalgia, and nausea. These reactions usually disappear on their own after 1-3 days.
In extremely rare cases - with high individual sensitivity, allergic reactions can be observed.
Drug Interactions
The vaccine can be used concurrently with other inactivated vaccines.
In this case, contraindications to each of the vaccines used should be taken into account, drugs should be administered to different parts of the body with different syringes.
Vaccination of patients receiving immunosuppressive therapy may be less effective.
Storage Conditions
At 2-8 РC (do not freeze).
Expiration
1 year.
Active ingredient
Vaccine for the prevention of influenza doped
Terms leave through pharmacies
In retseptu
lekarstvennaja form
Solution for
Submit your review to Earn 10 Reward Points click here to login
Write Your Own Review